Medical Physiology, 3rd Edition


Books and Reviews

Baron R, Hesse E. Update on bone anabolics in osteoporosis treatment: Rationale, current status and perspectives. J. Clin. Endocrinol. Metab.2012;97:311–325.

Baron R, Kneissel M. WNT Signaling in bone homeostasis and disease: From human mutations to treatments. Nature Med. 2013;19:179–192.

Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. Wilson JD, Foster DW, Kronenberg HM, Larsen PR. Williams Textbook of Endocrinology. 9th ed. WB Saunders: Philadelphia; 1998:1155–1209.

Datta HK, Ng WF, Walker JA, et al. The cell biology of bone metabolism. J. Clin. Pathol. 2008;61:577–587.

DeLuca HF. The transformation of a vitamin into a hormone: The vitamin D story. Harvey Lect. 1979–1980;75:333–379.

Habener JF, Rosenblatt M, Potts JT Jr. Parathyroid hormone: Biochemical aspects of biosynthesis, secretion, action, and metabolism. Physiol Rev. 1984;64:985–1053.

Jones G, Strugnell SA, DeLuca HD. Current understanding of the molecular actions of vitamin D. Physiol Rev. 1998;78:1193–1231.

Murer H, Forster I, Hilfiker H, et al. Cellular/molecular control of renal Na/Pi-cotransport. Kidney Int Suppl. 1998;65:2–10.

Journal Articles

Broadus AE, Mangin M, Ikeda K, et al. Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone–like peptide. N Engl J Med. 1988;319:556–563.

Brown EM, Gamba G, Riccardi D, et al. Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature. 1993;366:575–580.

Burgess TL, Qian Y, Kaufman S, et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol. 1999;145:527–538.

Robertson RP, Khosla S. Osteoporosis update. Transl Endocrinol Metab. 2010;1:1–154.